Testing a new medication's safety and how food affects it

This is an early-stage clinical trial testing a new experimental medication called IMM-H014. Researchers want to understand whether the medication is safe, how well people tolerate it, how the body processes it, and whether eating food changes how the body absorbs and uses it. The study involves 138 healthy adult volunteers who will receive different doses of the medication or a placebo (a dummy pill with no active ingredient).

Before this medication can be tested in patients with liver disease (the condition it's eventually meant to treat), researchers need to confirm it's safe in healthy people and understand how the body handles it. This information is essential before moving forward with studies in patients who actually have the disease.